Search
Menu
Home
Sources
About
Contacts
Panomifene
Panomifene
is a
nonsteroidal
selective estrogen receptor modulator
of the
triphenylethylene
group related to
tamoxifen
that was
under development
as an
antineoplastic agent
by
Egis Pharmaceuticals
and
IVAX Drug Research Institute
in
the 1990s
for the
treatment
of
breast cancer
but was not
marketed
. It
reached
phase II
clinical trials
before
development
was terminated. The drug was described in
1981
.
